ADOREG - development and establishment of a nationwide prospective register for Health Services Research in dermatologic oncology

ADOREG - development and establishment of a nationwide prospective register for Health Services Research in dermatologic oncology - ADOREG

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006123

Enrollment

20000

Registered

2016-05-04

Start date

2013-09-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In Pilotphase Malignant Melanoma from Stage IIB, after pilotphase Epithelial Skin Cancer and Actinic Keratosis C43-C44

Interventions

Group 1: prospective data collection in a register of patients with Skin Cancer: - Malignant Melanoma from Stage IIB (Pilotphase) - Epithelial Skin Cancer - Actinic Keratosis

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Malignant Melanoma from Stage IIB (Pilotphase) - Epithelial Skin Cancer - Actinic Keratosis

Exclusion criteria

Exclusion criteria: No sign / confirmation of Malignant Melanoma from Stage IIB, Epithelial Skin Cancers or Actinic Ceratosis

Design outcomes

Primary

Measure	Time frame
Prospective informations about courses of treatments of patients with Malignant Melanoma from Stage IIB (Pilotphase) and also patients with epithelial Skin Cancer and Actinic Keratosis will begatherd via online portal ODM QuaSI. This is an unlimited register study.	—

Secondary

Measure	Time frame
Process of Health Care and Therapy	—

Countries

Germany

Contacts

Public ContactDirk Schadendorf

Uniklinik Essen, Hautklinik

Dirk.Schadendorf@uk-essen.de+492017234342

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026